Large-scale testing (Phase 3)Study completedNCT02968173
What this trial is testing
Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 50